GSK's Cervarix may have been the first HPV shot approved in mainland China, but Merck's Gardasil now has an opening to gain the lead.
Serum Institute of India CEO Adar Poonawalla struck a deal on Tuesday to pick up a defunct Czech outfit for €72 million.
WHO plans real-world pilot studies of GlaxoSmithKline’s malaria jab Mosquirix in three African countries.
Vaccination rates among kindergarteners reached a record high in California after a tougher vaccine law went into effect.
Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia.
GlaxoSmithKline’s U.S. vaccine R&D head Ripley Ballou says emerging disease vaccine research needs a shakeup—and here's how.
Sanofi Pasteur agreed to pay more than $19.8 million to settle allegations that it overcharged the Department of Veterans Affairs for its products.
Even as Pfizer’s vaccine outfit suffers a painful Prevnar 13 slowdown around the world, the group may soon get a boost in Europe.
The U.S. government is pumping more money into anthrax bioterror preparedness.
Sen. Sanders blasted a proposed Zika license, saying Americans shouldn't have to "pay the highest price in the world for a vaccine we paid to help…